Sutro Biopharma (STRO) Capital Expenditures (QoQ) (2018 - 2025)
Powered by 
Analysis
Sutro Biopharma (STRO) Capital Expenditures (QoQ) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Sutro Biopharma | 334.66 Mn | 170.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -26.69% |
| Sep 30, 2025 | 191.86% |
| Jun 30, 2025 | -92.67% |
| Mar 31, 2025 | 9.93% |
| Dec 31, 2024 | 28.99% |
| Sep 30, 2024 | 9.52% |
| Jun 30, 2024 | 69.51% |
| Mar 31, 2024 | -69.05% |
| Dec 31, 2023 | 339.33% |
| Sep 30, 2023 | -79.55% |
| Jun 30, 2023 | 70.28% |
| Mar 31, 2023 | -72.02% |
| Dec 31, 2022 | 356.23% |
| Sep 30, 2022 | -66.45% |
| Jun 30, 2022 | 41.66% |
| Mar 31, 2022 | -38.79% |
| Dec 31, 2021 | -49.23% |
| Sep 30, 2021 | -7.69% |
| Jun 30, 2021 | 127.82% |
| Mar 31, 2021 | 46.22% |